Merck Looks To Mid-June FDA Decision On Expanded Use Of Gardasil To Older Women
This article was originally published in The Pink Sheet Daily
Executive Summary
Company unveils data at European conference supporting use in women ages 27 through 45; data was sent to FDA late last year.